BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24792538)

  • 1. Prevention and control of Hb Bart's disease in Guangxi Zhuang Autonomous Region, China.
    He S; Zhang Q; Li D; Chen S; Tang Y; Chen Q; Zheng C
    Eur J Obstet Gynecol Reprod Biol; 2014 Jul; 178():138-41. PubMed ID: 24792538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive prenatal diagnosis of α-thalassemia to control Hb Bart's hydrops fetalis syndrome: 15 years of experience.
    Lai K; Li S; Lin W; Yang D; Chen W; Li M; Pang L; Chen P
    Arch Gynecol Obstet; 2018 Aug; 298(2):307-311. PubMed ID: 29948167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal control of Hb Bart's disease in southern China.
    Liao C; Li Q; Wei J; Feng Q; Li J; Huang Y; Li D
    Hemoglobin; 2007; 31(4):471-5. PubMed ID: 17994381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Hb Bart's (γ4) Disease Associated with the - -(THAI) α(0)-Thalassemia Deletion in Mainland China.
    Li DZ; Li Y; Li J; Li SC; Li R
    Hemoglobin; 2015; 39(6):412-4. PubMed ID: 26212676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal eradication of Hb Bart's hydrops fetalis.
    Tongsong T; Wanapirak C; Sirivatanapa P; Sa-nguansermsri T; Sirichotiyakul S; Piyamongkol W; Chanprapaph P; Steger HF; Sekararithi R; Tuggapichitti A
    J Reprod Med; 2001 Jan; 46(1):18-22. PubMed ID: 11209626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of red blood cell hematology among normal, alpha-thalassemia-1 trait, and hemoglobin Bart's fetuses at mid-pregnancy.
    Srisupundit K; Piyamongkol W; Tongsong T
    Am J Hematol; 2008 Dec; 83(12):908-10. PubMed ID: 18932192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal control of nondeletional α-thalassemia: first experience in mainland China.
    Li J; Li R; Zhou JY; Xie XM; Liao C; Li DZ
    Prenat Diagn; 2013 Sep; 33(9):869-72. PubMed ID: 23637094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis of haemoglobin Bart's disease by cordocentesis at 12-14 weeks--experience with the first 59 cases.
    Lam YH; Tang MH
    Prenat Diagn; 2000 Nov; 20(11):900-4. PubMed ID: 11113892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate prenatal diagnosis of Hb Bart's hydrops fetalis in daily practice with a double-check PCR system.
    Karnpean R; Fucharoen G; Fucharoen S; Sae-ung N; Sanchaisuriya K; Ratanasiri T
    Acta Haematol; 2009; 121(4):227-33. PubMed ID: 19546525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of alpha-thalassemia in beta-thalassemia carriers and prevention of Hb Bart's hydrops fetalis through prenatal screening.
    Li D; Liao C; Li J; Xie X; Huang Y; Zhong H
    Haematologica; 2006 May; 91(5):649-51. PubMed ID: 16627247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental thickness at mid-pregnancy as a predictor of Hb Bart's disease.
    Tongsong T; Wanapirak C; Sirichotiyakul S
    Prenat Diagn; 1999 Nov; 19(11):1027-30. PubMed ID: 10589053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of fetal blood using capillary electrophoresis system: a simple method for prenatal diagnosis of severe thalassemia diseases.
    Srivorakun H; Fucharoen G; Sae-Ung N; Sanchaisuriya K; Ratanasiri T; Fucharoen S
    Eur J Haematol; 2009 Jul; 83(1):57-65. PubMed ID: 19226360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of haemoglobin Bart's disease by cordocentesis at 12-14 weeks' gestation.
    Lam YH; Tang MH
    Prenat Diagn; 1997 Jun; 17(6):501-4. PubMed ID: 9203207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal control of Hb Bart's hydrops fetalis: a two-year experience at a mainland Chinese hospital.
    Liao C; Pan M; Han J; Yang X; Zhen L; Li J; Li R; Li DZ
    J Matern Fetal Neonatal Med; 2015 Mar; 28(4):413-5. PubMed ID: 24766075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal control of Hb Bart's disease in mainland China: can we do better?
    He P; Yang Y; Li R; Li DZ
    Hemoglobin; 2014; 38(6):435-9. PubMed ID: 25317629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second trimester maternal serum markers and a predictive model for predicting fetal hemoglobin Bart's disease.
    Tongprasert F; Srisupundit K; Luewan S; Tongsong T
    J Matern Fetal Neonatal Med; 2013 Jan; 26(2):146-9. PubMed ID: 22989193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of maternal serum PlGF and sFlt-1 between pregnancies with and without fetal hemoglobin Bart's disease.
    Tongprasert F; Srisupundit K; Luewan S; Tongsong T
    Prenat Diagn; 2013 Dec; 33(13):1272-5. PubMed ID: 24122800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplified PGD of common determinants of haemoglobin Bart's hydrops fetalis syndrome using multiplex-microsatellite PCR.
    Wang W; Yap CH; Loh SF; Tan AS; Lim MN; Prasath EB; Chan ML; Tan WC; Jiang B; Yeo GH; Mathew J; Ho A; Ho SS; Wong PC; Choolani MA; Chong SS
    Reprod Biomed Online; 2010 Nov; 21(5):642-8. PubMed ID: 20864413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second trimester maternal serum inhibin-A in fetal anemia secondary to hemoglobin Bart's disease.
    Tongprasert F; Srisupundit K; Luewan S; Tongsong T
    J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1005-9. PubMed ID: 24107149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten years' experience in prenatal diagnosis of α-thalassemia in a municipal hospital and retrospective analysis of ultrasonic abnormalities.
    Li H; Wang J; Wang D; Gan Y; Xiong Y
    Int J Hematol; 2023 Sep; 118(3):355-363. PubMed ID: 37477864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.